S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
OTCMKTS:ATGN

Altigen Communications - ATGN Stock Forecast, Price & News

$1.08
-0.06 (-5.26%)
(As of 08/9/2022 05:18 PM ET)
Add
Compare
Today's Range
$1.02
$1.14
50-Day Range
$0.77
$1.25
52-Week Range
$0.70
$2.35
Volume
6,701 shs
Average Volume
54,086 shs
Market Capitalization
$26.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ATGN stock logo

About Altigen Communications (OTCMKTS:ATGN) Stock

Altigen Communications, Inc. designs, develops, markets, and supports integrated communications solutions worldwide. It provides MaxCS IP-PBX, a software-based phone system that provides customers with business communications solutions; MaxACD Voice Over Internet Protocol (VoIP) Contact Center, a software-based automatic call distribution engine, which offers call routing and call distribution options; MaxMobile that extends a set of business PBX functionality to smart phone devices; and MaxCommunicator, a Windows-based desktop application, which provides call control and visual voice mail management to the desktop. The company also offers MaxAgent, a Windows-based desktop application to bring call control and workgroup information to call center agents; MaxSupervisor, a Windows-based desktop application for call center supervisors; and MaxACD for Skype, a call center solution. In addition, it provides hosted services, which include hosted IP PBX, Skype for Business, session initiation protocol trunk, call center solution, voice and video calling, conference calling, and various long-distance services; and software assurance services, which offer customers with software updates, patches, new releases, and technical support for the applications they are licensed to use. The company offers its products primarily to financial services, healthcare, retail, and business services industries through a channel of distributors and resellers. Altigen Communications, Inc. was incorporated in 1994 and is headquartered in Milpitas, California.

Receive ATGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altigen Communications and its competitors with MarketBeat's FREE daily newsletter.

ATGN Stock News Headlines

Altigen Announces Workgroup Insights for CoreInteract
Altigen to Host Virtual Investor Day on March 8, 2022
See More Headlines
Receive ATGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Altigen Communications and its competitors with MarketBeat's FREE daily newsletter.

ATGN Company Calendar

Last Earnings
5/12/2022
Today
8/09/2022
Fiscal Year End
9/30/2022

Industry, Sector and Symbol

Industry
Telephone & telegraph apparatus
Sub-Industry
N/A
Current Symbol
OTCMKTS:ATGN
Employees
61
Year Founded
N/A

Profitability

Net Income
$-490,000.00
Pretax Margin
10.47%

Debt

Sales & Book Value

Annual Sales
$10.99 million
Cash Flow
$0.09 per share
Book Value
$0.61 per share

Miscellaneous

Free Float
20,832,000
Market Cap
$26.16 million
Optionable
Not Optionable
Beta
1.37

Key Executives

  • Mr. Jeremiah J. Fleming (Age 64)
    Chairman, Pres & CEO
  • Carolyn David
    VP of Fin. & Investor Relations Officer
  • Mr. Mark Allen
    VP of Technology & Alliances
  • Mr. Michael Plumer (Age 58)
    VP of Sales
  • Ms. Tsyr-Yi Sun (Age 62)
    VP of R&D
  • Mr. Joe Hamblin
    VP & GM of Altigen's Microsoft Teams Bus. Unit













ATGN Stock - Frequently Asked Questions

How has Altigen Communications' stock price performed in 2022?

Altigen Communications' stock was trading at $1.35 at the beginning of the year. Since then, ATGN shares have decreased by 15.6% and is now trading at $1.14.
View the best growth stocks for 2022 here
.

Are investors shorting Altigen Communications?

Altigen Communications saw a increase in short interest in July. As of July 15th, there was short interest totaling 11,800 shares, an increase of 145.8% from the June 30th total of 4,800 shares. Based on an average daily volume of 39,300 shares, the days-to-cover ratio is currently 0.3 days.
View Altigen Communications' Short Interest
.

How were Altigen Communications' earnings last quarter?

Altigen Communications, Inc. (OTCMKTS:ATGN) released its quarterly earnings data on Thursday, May, 12th. The technology company reported $0.01 earnings per share for the quarter. The technology company had revenue of $2.56 million for the quarter. Altigen Communications had a negative net margin of 1.23% and a positive trailing twelve-month return on equity of 9.10%.

What other stocks do shareholders of Altigen Communications own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Altigen Communications investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

What is Altigen Communications' stock symbol?

Altigen Communications trades on the OTCMKTS under the ticker symbol "ATGN."

How do I buy shares of Altigen Communications?

Shares of ATGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Altigen Communications' stock price today?

One share of ATGN stock can currently be purchased for approximately $1.14.

How much money does Altigen Communications make?

Altigen Communications (OTCMKTS:ATGN) has a market capitalization of $27.61 million and generates $10.99 million in revenue each year. The technology company earns $-490,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis.

How many employees does Altigen Communications have?

Altigen Communications employs 61 workers across the globe.

How can I contact Altigen Communications?

Altigen Communications' mailing address is 679 RIVER OAKS PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.altigen.com. The technology company can be reached via phone at (408) 597-9000, via email at ir@altigen.com, or via fax at 408-597-2020.

This page (OTCMKTS:ATGN) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.